ALAMEDA, CA - Sep 30, 2015 -- AllCells, LLC, (the “company”) a leading provider of hematologic tissue, primary cell products, and Bioservices that support life science research applications worldwide, today announced its Clinical Division, LeukoLab, received Institutional Review Board (IRB) approval to administer vaccines to clinically healthy human donors.As part of its expanded service offering LeukoLab is now able to vaccinate adult volunteer donors with vaccines such as Influenza (Flu)

Read More